Zamagni E - Search Results

1

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.

Mina R, Musto P, Rota-Scalabrini D, Paris L, Gamberi B, Palmas A, Aquino S, de Fabritiis P, Giuliani N, De Rosa L, Gozzetti A, Cellini C, Bertamini L, Capra A, Oddolo D, Vincelli ID, Ronconi S, Pavone V, Pescosta N, Cea M, Fioritoni F, Ballanti S, Grasso M, Zamagni E, Belotti A, Boccadoro M, Gay F. Mina R, et al. Among authors: zamagni e. Lancet Oncol. 2023 Jan;24(1):64-76. doi: 10.1016/S1470-2045(22)00693-3. Epub 2022 Dec 14. Lancet Oncol. 2023. PMID: 36528035 Clinical Trial.

2

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma.

Cavo M, Bandini G, Benni M, Gozzetti A, Ronconi S, Rosti G, Zamagni E, Lemoli RM, Bonini A, Belardinelli A, Motta MR, Rizzi S, Tura S. Cavo M, et al. Among authors: zamagni e. Bone Marrow Transplant. 1998 Jul;22(1):27-32. doi: 10.1038/sj.bmt.1701280. Bone Marrow Transplant. 1998. PMID: 9678792

3

In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells.

Tosi P, Pellacani A, Visani G, Ottaviani E, Ronconi S, Zamagni E, Benni M, Cavo M, Tura S. Tosi P, et al. Among authors: zamagni e. Eur J Haematol. 1999 Mar;62(3):143-8. doi: 10.1111/j.1600-0609.1999.tb01736.x. Eur J Haematol. 1999. PMID: 10089890

4

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy.

Lemoli RM, Martinelli G, Zamagni E, Motta MR, Rizzi S, Terragna C, Rondelli R, Ronconi S, Curti A, Bonifazi F, Tura S, Cavo M. Lemoli RM, et al. Among authors: zamagni e. Blood. 2000 Apr 1;95(7):2234-9. Blood. 2000. PMID: 10733490 Free article.

5

Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma.

Martinelli G, Terragna C, Zamagni E, Ronconi S, Tosi P, Lemoli RM, Bandini G, Motta MR, Testoni N, Amabile M, Ottaviani E, Vianelli N, de Vivo A, Gozzetti A, Tura S, Cavo M. Martinelli G, et al. Among authors: zamagni e. J Clin Oncol. 2000 Jun;18(11):2273-81. doi: 10.1200/JCO.2000.18.11.2273. J Clin Oncol. 2000. PMID: 10829048

6

Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma.

Cavo M, Terragna C, Martinelli G, Ronconi S, Zamagni E, Tosi P, Lemoli RM, Benni M, Pagliani G, Bandini G, Tura S. Cavo M, et al. Among authors: zamagni e. Blood. 2000 Jul 1;96(1):355-7. Blood. 2000. PMID: 10891473 Free article. Clinical Trial.

7

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.

Tosi P, Zamagni E, Ronconi S, Benni M, Motta MR, Rizzi S, Tura S, Cavo M. Tosi P, et al. Among authors: zamagni e. Leukemia. 2000 Jul;14(7):1310-3. doi: 10.1038/sj.leu.2401819. Leukemia. 2000. PMID: 10914557

8

Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation.

Martinelli G, Terragna C, Zamagni E, Ronconi S, Tosi P, Lemoli R, Bandini G, Testoni N, Amabile M, Ottaviani E, Buonamici S, Soverini S, Montefusco V, de Vivo A, Bonifazi F, Tura S, Cavo M. Martinelli G, et al. Among authors: zamagni e. Haematologica. 2000 Sep;85(9):930-4. Haematologica. 2000. PMID: 10980631

9

Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.

Tosi P, Ronconi S, Zamagni E, Cellini C, Grafone T, Cangini D, Pileri SA, Baccarani M, Tura S, Cavo M. Tosi P, et al. Among authors: zamagni e. Haematologica. 2001 Apr;86(4):409-13. Haematologica. 2001. PMID: 11325648 Clinical Trial.

10

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.

Tosi P, Zamagni E, Cellini C, Ronconi S, Patriarca F, Ballerini F, Musto P, Di Raimondo F, Ledda A, Lauria F, Masini L, Gobbi M, Vacca A, Ria R, Cangini D, Tura S, Baccarani M, Cavo M. Tosi P, et al. Among authors: zamagni e. Haematologica. 2002 Apr;87(4):408-14. Haematologica. 2002. PMID: 11940485 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters